Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Comparison Study of the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly Suspension to Sitagliptin and Placebo in Subjects With Type 2 Diabetes Mellitus

ClinicalTrials.gov ID: NCT01652729

Public ClinicalTrials.gov record NCT01652729. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 6:59 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Long-Term, Open-Label, 3-Arm, Multicenter Study to Compare the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly Suspension to Sitagliptin and Placebo in Subjects With Type 2 Diabetes Mellitus

Study identification

NCT ID
NCT01652729
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
365 participants

Conditions and interventions

Interventions

  • Exenatide once weekly suspension Drug
  • Sitagliptin Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2013
Primary completion
Mar 31, 2014
Completion
Mar 31, 2014
Last update posted
Aug 19, 2015

2013 – 2014

United States locations

U.S. sites
60
U.S. states
22
U.S. cities
53
Facility City State ZIP Site status
Research Site Birmingham Alabama 35216
Research Site Huntsville Alabama 35801
Research Site Phoenix Arizona 85018
Research Site Phoenix Arizona 85020
Research Site Beverly Hills California 90036
Research Site Buena Park California 90620
Research Site Chino California 91710
Research Site Chula Vista California 91910
Research Site Encinitas California 92024
Research Site Greenbrae California 94904
Research Site Los Angeles California 90057
Research Site Los Angeles California 90059
Research Site North Hollywood California 91606
Research Site Walnut Creek California 94598
Research Site West Hills California 91307
Research Site Boca Raton Florida 33432
Research Site Hialeah Florida 33012
Research Site Miami Florida 33143
Research Site Miami Florida 33169
Research Site Miami Florida 33183
Research Site Port Orange Florida 32127
Research Site St. Petersburg Florida 33709
Research Site Chicago Illinois 60607
Research Site Evanston Illinois 60201
Research Site Indianapolis Indiana 46254
Research Site Oxon Hill Maryland 20745
Research Site Omaha Nebraska 68130
Research Site Henderson Nevada 89052
Research Site Las Vegas Nevada 89101
Research Site Las Vegas Nevada 89123
Research Site Albuquerque New Mexico 87102
Research Site Buffalo New York 14215
Research Site Hartsdale New York 10530
Research Site Charlotte North Carolina 28204
Research Site Clayton North Carolina 27520
Research Site Durham North Carolina 27710
Research Site Greensboro North Carolina 27410
Research Site Mooresville North Carolina 28117
Research Site Salisbury North Carolina 28144
Research Site Cincinnati Ohio 45246
Research Site Franklin Ohio 45005
Research Site Marion Ohio 43302
Research Site Yukon Oklahoma 73099
Research Site Eugene Oregon 97404
Research Site Portland Oregon 97210
Research Site Greer South Carolina 29651
Research Site Simpsonville South Carolina 29681
Reseach Site Rapid City South Dakota 57702
Research Site Chattanooga Tennessee 37421
Research Site Carrolton Texas 75007
Research Site Corpus Christi Texas 78404
Research Site Dallas Texas 75390
Research Site Houston Texas 77072
Research Site Houston Texas 77074
Research Site Katy Texas 77450
Research Site San Antonio Texas 78205
Research Site Salt Lake City Utah 84095
Research Site Salt Lake City Utah 84107
Research Site Burke Virginia 22015
Research Site Spokane Washington 99202

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01652729, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 19, 2015 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01652729 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →